| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 52.513 | 63.594 | 52.037 | 65.871 | 64.757 | 52.005 | 29.957 | 59.674 | 71.781 | 60.341 |
| Total Income - EUR | 52.737 | 63.594 | 52.799 | 65.871 | 74.166 | 52.005 | 29.957 | 59.682 | 71.781 | 60.341 |
| Total Expenses - EUR | 46.388 | 56.273 | 52.205 | 53.341 | 58.844 | 52.079 | 31.033 | 52.663 | 61.157 | 65.186 |
| Gross Profit/Loss - EUR | 6.348 | 7.321 | 594 | 12.530 | 15.322 | -74 | -1.077 | 7.019 | 10.624 | -4.845 |
| Net Profit/Loss - EUR | 4.766 | 5.780 | -707 | 10.554 | 13.413 | -488 | -1.922 | 5.229 | 9.177 | -4.845 |
| Employees | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 |
Check the financial reports for the company - Drogeanex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.526 | 1.248 | 31.737 | 57.672 | 249 | 25.066 | 20.413 | 0 | 0 | 0 |
| Current Assets | 8.797 | 8.309 | 7.080 | 13.898 | 15.488 | 11.199 | 6.263 | 9.969 | 17.317 | 14.427 |
| Inventories | 583 | 1.860 | 4.265 | 3.595 | 2.301 | 1.022 | 3.732 | 4.963 | 3.771 | 7.794 |
| Receivables | 0 | 0 | 0 | 0 | 492 | 0 | 0 | 0 | 4.372 | 590 |
| Cash | 8.214 | 6.449 | 2.815 | 10.303 | 12.695 | 10.178 | 2.531 | 5.006 | 9.175 | 6.042 |
| Shareholders Funds | 7.034 | 5.834 | -655 | 9.911 | 13.463 | -438 | -2.351 | 2.871 | 12.039 | 7.127 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.290 | 3.723 | 39.472 | 61.659 | 2.273 | 36.704 | 29.026 | 7.098 | 5.278 | 7.300 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Drogeanex Srl